Noble Biomaterials Acquires Carolina Silver
Manufacturer of X-STATIC® silver fiber technology aquires Carolina Silver, LLC, a full-service manufacturer of silver-based fabric, yarn and fiber.
Get access to everything we publish when you sign up for Outside+.
Scranton, PA: Noble Biomaterials Inc., the global leader in bacterial management solutions and manufacturer of X-STATIC® silver fiber technology, announced today the acquisition of Carolina Silver, LLC, a full-service manufacturer of silver-based fabric, yarn and fiber.
Based in Maiden, North Carolina, Carolina Silver’s advanced facility is located in the heart of the North American textile industry and has been offering customers a wide range of anti-bacterial and conductive technology solutions since 2003. Carolina Silver‘s technologies provide proprietary solutions to the wound care, military and industrial markets places under the AG3+ brand.
“Carolina Silver has been a leader within the silver textile solutions industry,” said Jeff Keane, CEO of Noble Biomaterials. “Its technologies will support the growth of the X-STATIC brand in preventing infections, healing wounds and eliminating odor.”
“The integration of Carolina’s technologies into Noble’s best in class business model and global sales capability will allow us to reach many more customers around the world,” said Jerry Finney, CEO of Carolina Silver.
Made with 99.9% pure silver, X-STATIC® is the premier silver antimicrobial technology designed to protect products from bacteria, fungi and odor. It naturally inhibits the growth of bacteria in apparel and textiles permanently; preventing the spread of infection, healing chronic wounds and keeping athletic gear smelling fresher and lasting longer.
Noble Biomaterials Inc. was advised by Dechert LLP and Brookwood Associates.
X-STATIC® is a registered trademark of Noble Fiber Technologies, LLC. Headquartered in Scranton, PA, Noble Biomaterials, Inc. develops, manufactures, sells and markets advanced antimicrobial technologies designed to manage all forms of bacterial contamination. It has more than 200 global licensees for products in the medical, defense, industrial and consumer markets and the company’s headquarters and manufacturing facilities are located in Scranton, PA, with global offices in Europe, Asia and South America. For more information, visit www.noblebiomaterials.com